Cargando…
STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development
Tertiary lymphoid structures (TLS), also known as ectopic lymphoid structures (ELS) or tertiary lymphoid organs (TLO), represent a unique subset of lymphoid tissues noted for their architectural similarity to lymph nodes, but which conditionally form in peripheral tissues in a milieu of sustained in...
Autores principales: | Filderman, Jessica N., Appleman, Mark, Chelvanambi, Manoj, Taylor, Jennifer L., Storkus, Walter J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8155498/ https://www.ncbi.nlm.nih.gov/pubmed/34054879 http://dx.doi.org/10.3389/fimmu.2021.690105 |
Ejemplares similares
-
STING agonist-based treatment promotes vascular normalization and tertiary lymphoid structure formation in the therapeutic melanoma microenvironment
por: Chelvanambi, Manoj, et al.
Publicado: (2021) -
STING Agonists as Cancer Therapeutics
por: Amouzegar, Afsaneh, et al.
Publicado: (2021) -
Cutaneous Melanoma: Mutational Status and Potential Links to Tertiary Lymphoid Structure Formation
por: Salem, Deepak, et al.
Publicado: (2021) -
Finding the right help in the tumor microenvironment
por: Filderman, Jessica N., et al.
Publicado: (2022) -
Therapeutic Use of Dendritic Cells to Promote the Extranodal Priming of Anti-Tumor Immunity
por: Chen, Lu, et al.
Publicado: (2013)